References
- Bleakley S, Olofinjana O, Taylor D. Which antipsychotics would mental health professionals take themselves? Psychiatr Bull 2007;31:94–6.
- Rettenbacher MA, Burns T, Kemmler G, Fleischhacker WW. Schizophrenia: Attitudes of patients and professional carers towards the illness and antipsychotic medication. Pharmacopsychiatry 2004;37:103–9.
- Steinert T. Which neuroleptic would psychiatrists take for themselves or their relatives? Eur Psychiatry 2003;18:40–1.
- Taylor M, Brown T. “Do unto others as…” – which treatments do psychiatrists prefer? Scott Med J 2007;52:17–19.
- Taylor M. Antipsychotics preferred by mental health professionals. The columns correspondence. Psychiatr Bull 2007; 31:272.
- Underwood BR. Dominance of second generation antipsychotics – time for reflection? Psychiatr Bull 2007;31:233.
- Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO . Practice guidelines for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004;161:1–56.
- Ganatra HA, Bhurgri H, Channa R, Bawany FA, Zafar SN, Chaudhry RI, . Educating and informing patients receiving psychopharmacological medications: Are family physicians in Pakistan up to the task? PLoS ONE 2009;4(2):e4620 [published online].
- Petersen T, Dording C, Neault NB, Kornbluh R, Alpert JE, Nierenberg AA, . A survey of prescribing practices in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry 2002;26(1):177–87.
- Owen RR, Feng W, Thrush CR, Hudson TJ, Austen MA. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs Hospitals. Psychiatr Serv 2001;52:1523–5.
- Walkup JT, McAlpine DD, Olfson M, Labay L, Boyer CA, Hansell S. Patients with schizophrenia at risk for excessive antipsychotic dosing. J Clin Psychiatry 2000;61:344–8.
- Husain N, Creed F, Tomenson B. Depression and social stress in Pakistan. Psychol Med 2000;30:395–402.
- Mirza I, Jenkins R. Risk factors, prevalence, and treatment of anxiety and depressive disorders in Pakistan: systematic review. Br Med J 2004;3:328(7443):794.
- Nierenberg AA. The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations? J Clin Psychiatry 1994;55(Suppl A):55–9.
- Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 2000;58(1):19–36.
- Hirschfeld RM. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. J Clin Psychiatry 1999;60(5):326–35.
- Broquet KE. Status of treatment of depression. South Med J 1999;92(9):846–56.